| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | HSPG2 FBLN1 MEGF6 DLL3 LRP1 CRELD2 LRP1B NOTCH3 MASP2 RAB11FIP3 | 3.24e-06 | 749 | 43 | 10 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.05e-05 | 188 | 43 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 5.33e-04 | 16 | 43 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 8.12e-04 | 85 | 43 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 9.27e-04 | 21 | 43 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 1.54e-03 | 27 | 43 | 2 | GO:0005044 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.29e-03 | 33 | 43 | 2 | GO:0005217 | |
| MousePheno | thin tail | 7.57e-05 | 6 | 32 | 2 | MP:0000589 | |
| MousePheno | short limbs | 1.14e-04 | 111 | 32 | 4 | MP:0000547 | |
| MousePheno | abnormal aorta morphology | 1.46e-04 | 225 | 32 | 5 | MP:0000272 | |
| MousePheno | abnormal compact bone thickness | 1.64e-04 | 122 | 32 | 4 | MP:0000134 | |
| MousePheno | transposition of great arteries | 1.65e-04 | 47 | 32 | 3 | MP:0004110 | |
| Domain | GAGE | GAGE4 GAGE5 GAGE6 GAGE13 GAGE12J GAGE12H GAGE1 GAGE12F GAGE12I GAGE2E | 8.80e-21 | 24 | 48 | 10 | PF05831 |
| Domain | GAGE_fam | GAGE4 GAGE5 GAGE6 GAGE13 GAGE12J GAGE12H GAGE1 GAGE12F GAGE12I GAGE2E | 1.46e-20 | 25 | 48 | 10 | IPR008625 |
| Domain | EGF | SCARF1 PCSK5 HSPG2 FBLN1 NTNG2 MEGF6 ATRAID DLL3 LRP1 NTNG1 CRELD2 LRP1B TNXB NOTCH3 MASP2 | 1.51e-17 | 235 | 48 | 15 | SM00181 |
| Domain | EGF-like_dom | SCARF1 PCSK5 HSPG2 FBLN1 NTNG2 MEGF6 ATRAID DLL3 LRP1 NTNG1 CRELD2 LRP1B TNXB NOTCH3 MASP2 | 3.62e-17 | 249 | 48 | 15 | IPR000742 |
| Domain | EGF_3 | SCARF1 HSPG2 FBLN1 NTNG2 MEGF6 ATRAID DLL3 LRP1 NTNG1 CRELD2 LRP1B TNXB NOTCH3 MASP2 | 5.58e-16 | 235 | 48 | 14 | PS50026 |
| Domain | EGF_1 | SCARF1 HSPG2 FBLN1 NTNG2 MEGF6 ATRAID DLL3 LRP1 NTNG1 CRELD2 LRP1B TNXB NOTCH3 MASP2 | 1.75e-15 | 255 | 48 | 14 | PS00022 |
| Domain | EGF-like_CS | SCARF1 HSPG2 FBLN1 NTNG2 MEGF6 ATRAID DLL3 LRP1 NTNG1 CRELD2 LRP1B TNXB NOTCH3 MASP2 | 2.41e-15 | 261 | 48 | 14 | IPR013032 |
| Domain | EGF_2 | SCARF1 HSPG2 FBLN1 NTNG2 MEGF6 ATRAID DLL3 LRP1 NTNG1 CRELD2 LRP1B TNXB NOTCH3 MASP2 | 2.98e-15 | 265 | 48 | 14 | PS01186 |
| Domain | Growth_fac_rcpt_ | SCARF1 PCSK5 HSPG2 FBLN1 MEGF6 DLL3 LRP1 CRELD2 LRP1B TNXB NOTCH3 | 1.67e-13 | 156 | 48 | 11 | IPR009030 |
| Domain | EGF_CA | 2.17e-11 | 122 | 48 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.52e-11 | 124 | 48 | 9 | IPR001881 | |
| Domain | EGF_extracell | 1.63e-10 | 60 | 48 | 7 | IPR013111 | |
| Domain | EGF_2 | 1.63e-10 | 60 | 48 | 7 | PF07974 | |
| Domain | Laminin_EGF | 5.41e-10 | 38 | 48 | 6 | IPR002049 | |
| Domain | GAGE | 1.02e-09 | 19 | 48 | 5 | SM01379 | |
| Domain | GAGE | 1.02e-09 | 19 | 48 | 5 | IPR031320 | |
| Domain | EGF | 1.03e-09 | 126 | 48 | 8 | PF00008 | |
| Domain | EGF_CA | 2.16e-09 | 86 | 48 | 7 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 5.06e-09 | 97 | 48 | 7 | IPR018097 | |
| Domain | EGF_CA | 5.84e-09 | 99 | 48 | 7 | PS01187 | |
| Domain | ASX_HYDROXYL | 6.27e-09 | 100 | 48 | 7 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 9.44e-09 | 106 | 48 | 7 | IPR000152 | |
| Domain | Laminin_EGF | 2.77e-08 | 35 | 48 | 5 | PF00053 | |
| Domain | EGF_Lam | 1.90e-06 | 35 | 48 | 4 | SM00180 | |
| Domain | DUF5050 | 6.47e-06 | 2 | 48 | 2 | IPR032485 | |
| Domain | DUF5050 | 6.47e-06 | 2 | 48 | 2 | PF16472 | |
| Domain | cEGF | 3.97e-05 | 26 | 48 | 3 | IPR026823 | |
| Domain | cEGF | 3.97e-05 | 26 | 48 | 3 | PF12662 | |
| Domain | hEGF | 4.99e-05 | 28 | 48 | 3 | PF12661 | |
| Domain | EGF_LAM_2 | 6.16e-05 | 30 | 48 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 6.16e-05 | 30 | 48 | 3 | PS01248 | |
| Domain | LDLR_class-A_CS | 1.47e-04 | 40 | 48 | 3 | IPR023415 | |
| Domain | Ldl_recept_a | 2.10e-04 | 45 | 48 | 3 | PF00057 | |
| Domain | - | 2.24e-04 | 46 | 48 | 3 | 4.10.400.10 | |
| Domain | LDLRA_1 | 2.54e-04 | 48 | 48 | 3 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 2.70e-04 | 49 | 48 | 3 | IPR002172 | |
| Domain | LDLa | 2.70e-04 | 49 | 48 | 3 | SM00192 | |
| Domain | LDLRA_2 | 2.70e-04 | 49 | 48 | 3 | PS50068 | |
| Domain | Ldl_recept_b | 5.77e-04 | 14 | 48 | 2 | PF00058 | |
| Domain | LDLRB | 5.77e-04 | 14 | 48 | 2 | PS51120 | |
| Domain | LY | 6.65e-04 | 15 | 48 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 6.65e-04 | 15 | 48 | 2 | IPR000033 | |
| Domain | LAMININ_NTER | 7.58e-04 | 16 | 48 | 2 | PS51117 | |
| Domain | Laminin_N | 7.58e-04 | 16 | 48 | 2 | PF00055 | |
| Domain | Laminin_N | 7.58e-04 | 16 | 48 | 2 | IPR008211 | |
| Domain | LamNT | 7.58e-04 | 16 | 48 | 2 | SM00136 | |
| Domain | Furin_repeat | 9.64e-04 | 18 | 48 | 2 | IPR006212 | |
| Domain | FU | 9.64e-04 | 18 | 48 | 2 | SM00261 | |
| Domain | - | 4.51e-03 | 39 | 48 | 2 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 6.23e-03 | 46 | 48 | 2 | IPR011042 | |
| Domain | Sushi | 7.90e-03 | 52 | 48 | 2 | PF00084 | |
| Domain | CCP | 8.50e-03 | 54 | 48 | 2 | SM00032 | |
| Domain | SUSHI | 9.12e-03 | 56 | 48 | 2 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 9.43e-03 | 57 | 48 | 2 | IPR000436 | |
| Pubmed | An overview of the GAGE cancer/testis antigen family with the inclusion of newly identified members. | GAGE4 GAGE5 GAGE6 GAGE7 GAGE13 GAGE12J GAGE12H GAGE1 GAGE12F GAGE12I GAGE2E | 2.76e-27 | 20 | 50 | 11 | 18179644 |
| Pubmed | 9.79e-19 | 10 | 50 | 7 | 9651357 | ||
| Pubmed | Characterization of the GAGE genes that are expressed in various human cancers and in normal testis. | 2.69e-18 | 11 | 50 | 7 | 10397259 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | GAGE5 GAGE6 GAGE7 GAGE13 GAGE12J GAGE12G GAGE1 GAGE12F GAGE12I GAGE2E | 1.37e-15 | 119 | 50 | 10 | 28625976 |
| Pubmed | 6.27e-13 | 9 | 50 | 5 | 7544395 | ||
| Pubmed | 7.74e-07 | 118 | 50 | 5 | 21078624 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 30871606 | ||
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 2.03e-06 | 2 | 50 | 2 | 15963947 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 26746425 | ||
| Pubmed | Laminets: laminin- and netrin-related genes expressed in distinct neuronal subsets. | 2.03e-06 | 2 | 50 | 2 | 11906208 | |
| Pubmed | Human netrin-G1 isoforms show evidence of differential expression. | 2.03e-06 | 2 | 50 | 2 | 15901489 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 17507910 | ||
| Pubmed | Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. | 2.03e-06 | 2 | 50 | 2 | 21681796 | |
| Pubmed | Netrin-G2 dysfunction causes a Rett-like phenotype with areflexia. | 2.03e-06 | 2 | 50 | 2 | 31692205 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 20101615 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 15705354 | ||
| Pubmed | 5.37e-06 | 175 | 50 | 5 | 28071719 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 20472562 | ||
| Pubmed | Characterization of Pitx2c expression in the mouse heart using a reporter transgene. | 6.07e-06 | 3 | 50 | 2 | 21089073 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 35454329 | ||
| Pubmed | Genetics of migraine in the age of genome-wide association studies. | 6.07e-06 | 3 | 50 | 2 | 22072275 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 21666692 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 7.36e-06 | 86 | 50 | 4 | 28327460 | |
| Pubmed | Identification of transcriptional regulatory elements for Ntng1 and Ntng2 genes in mice. | 1.21e-05 | 4 | 50 | 2 | 24642214 | |
| Pubmed | Structural basis for cell surface patterning through NetrinG-NGL interactions. | 1.21e-05 | 4 | 50 | 2 | 21946559 | |
| Pubmed | Netrin-G/NGL complexes encode functional synaptic diversification. | 1.21e-05 | 4 | 50 | 2 | 25411505 | |
| Pubmed | Axonal netrin-Gs transneuronally determine lamina-specific subdendritic segments. | 1.21e-05 | 4 | 50 | 2 | 17785411 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 33086060 | ||
| Pubmed | Complementary expression and neurite outgrowth activity of netrin-G subfamily members. | 1.21e-05 | 4 | 50 | 2 | 11804778 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 1.39e-05 | 101 | 50 | 4 | 20551380 | |
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 21289173 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 27583843 | ||
| Pubmed | 2.55e-05 | 407 | 50 | 6 | 15772651 | ||
| Pubmed | Pcsk5 is required in the early cranio-cardiac mesoderm for heart development. | 3.03e-05 | 6 | 50 | 2 | 28446132 | |
| Pubmed | Nidogen-2: a new basement membrane protein with diverse binding properties. | 3.03e-05 | 6 | 50 | 2 | 9733643 | |
| Pubmed | Tropoelastin binding to fibulins, nidogen-2 and other extracellular matrix proteins. | 3.03e-05 | 6 | 50 | 2 | 10544250 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 4.35e-05 | 135 | 50 | 4 | 28675934 | |
| Pubmed | Loss of Cited2 causes congenital heart disease by perturbing left-right patterning of the body axis. | 5.64e-05 | 8 | 50 | 2 | 21224256 | |
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 11847210 | ||
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 1383086 | ||
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 37709743 | ||
| Pubmed | A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16. | 5.64e-05 | 8 | 50 | 2 | 24563484 | |
| Pubmed | In vivo evidence for a bridging role of a collagen V subtype at the epidermis-dermis interface. | 5.64e-05 | 8 | 50 | 2 | 22437311 | |
| Pubmed | 3D Mapping Reveals a Complex and Transient Interstitial Matrix During Murine Kidney Development. | 5.64e-05 | 8 | 50 | 2 | 33875569 | |
| Pubmed | 5.91e-05 | 146 | 50 | 4 | 27068509 | ||
| Pubmed | 7.08e-05 | 153 | 50 | 4 | 25037231 | ||
| Pubmed | Perlecan is essential for cartilage and cephalic development. | 7.25e-05 | 9 | 50 | 2 | 10545953 | |
| Pubmed | 7.25e-05 | 9 | 50 | 2 | 11118901 | ||
| Pubmed | 7.25e-05 | 9 | 50 | 2 | 16245338 | ||
| Pubmed | 7.25e-05 | 9 | 50 | 2 | 12122015 | ||
| Pubmed | Coordinate Nodal and BMP inhibition directs Baf60c-dependent cardiomyocyte commitment. | 7.25e-05 | 9 | 50 | 2 | 24186978 | |
| Pubmed | 7.25e-05 | 9 | 50 | 2 | 15081423 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 9.05e-05 | 10 | 50 | 2 | 23665443 | |
| Pubmed | TBX1 Regulates Chondrocyte Maturation in the Spheno-occipital Synchondrosis. | 9.05e-05 | 10 | 50 | 2 | 32442036 | |
| Pubmed | A modifier in the 129S2/SvPasCrl genome is responsible for the viability of Notch1[12f/12f] mice. | 9.05e-05 | 10 | 50 | 2 | 31590629 | |
| Pubmed | 1.10e-04 | 64 | 50 | 3 | 22261194 | ||
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 1.10e-04 | 11 | 50 | 2 | 38303699 | |
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 1.10e-04 | 11 | 50 | 2 | 7500359 | |
| Pubmed | 1.10e-04 | 11 | 50 | 2 | 2745554 | ||
| Pubmed | 1.10e-04 | 11 | 50 | 2 | 10878608 | ||
| Pubmed | 1.10e-04 | 11 | 50 | 2 | 24639464 | ||
| Pubmed | Basement membrane remodelling regulates mouse embryogenesis. | 1.10e-04 | 11 | 50 | 2 | 32523119 | |
| Pubmed | 1.32e-04 | 12 | 50 | 2 | 30883226 | ||
| Pubmed | NGL family PSD-95-interacting adhesion molecules regulate excitatory synapse formation. | 1.32e-04 | 12 | 50 | 2 | 16980967 | |
| Pubmed | 1.32e-04 | 12 | 50 | 2 | 15465494 | ||
| Pubmed | 1.32e-04 | 12 | 50 | 2 | 14732396 | ||
| Pubmed | Node and midline defects are associated with left-right development in Delta1 mutant embryos. | 1.56e-04 | 13 | 50 | 2 | 12441287 | |
| Pubmed | 1.56e-04 | 13 | 50 | 2 | 12682087 | ||
| Pubmed | Gene expression changes in the secondary palate and mandible of Prdm16(-/-) mice. | 1.56e-04 | 13 | 50 | 2 | 23149718 | |
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 1.56e-04 | 13 | 50 | 2 | 11578869 | |
| Pubmed | 1.56e-04 | 13 | 50 | 2 | 10906448 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.66e-04 | 1105 | 50 | 8 | 35748872 | |
| Pubmed | Membrane-type MMPs are indispensable for placental labyrinth formation and development. | 1.82e-04 | 14 | 50 | 2 | 20858856 | |
| Pubmed | Association of polymorphisms in the SLIT2 axonal guidance gene with anger in suicide attempters. | 1.82e-04 | 14 | 50 | 2 | 20029409 | |
| Pubmed | 1.82e-04 | 14 | 50 | 2 | 15082773 | ||
| Pubmed | 1.82e-04 | 14 | 50 | 2 | 14757642 | ||
| Pubmed | 1.82e-04 | 14 | 50 | 2 | 26453377 | ||
| Pubmed | 2.10e-04 | 15 | 50 | 2 | 10780854 | ||
| Pubmed | 2.10e-04 | 15 | 50 | 2 | 12971992 | ||
| Pubmed | Hedgehog-FGF signaling axis patterns anterior mesoderm during gastrulation. | 2.10e-04 | 15 | 50 | 2 | 32561646 | |
| Pubmed | 2.10e-04 | 15 | 50 | 2 | 10330372 | ||
| Pubmed | 2.10e-04 | 15 | 50 | 2 | 11171400 | ||
| Pubmed | COUP-TFI controls Notch regulation of hair cell and support cell differentiation. | 2.10e-04 | 15 | 50 | 2 | 16914494 | |
| Pubmed | Ontogeny of stromal organizer cells during lymph node development. | 2.40e-04 | 16 | 50 | 2 | 20237296 | |
| Pubmed | 2.40e-04 | 16 | 50 | 2 | 11564885 | ||
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 2.40e-04 | 16 | 50 | 2 | 12617809 | |
| Pubmed | Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. | 2.40e-04 | 16 | 50 | 2 | 11739954 | |
| Pubmed | Imaging proprotein convertase activities and their regulation in the implanting mouse blastocyst. | 2.40e-04 | 16 | 50 | 2 | 20876279 | |
| Pubmed | Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation. | 2.40e-04 | 16 | 50 | 2 | 21067603 | |
| Pubmed | 2.72e-04 | 17 | 50 | 2 | 18694942 | ||
| Pubmed | Nucleoredoxin sustains Wnt/β-catenin signaling by retaining a pool of inactive dishevelled protein. | 2.72e-04 | 17 | 50 | 2 | 20970343 | |
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 2.72e-04 | 17 | 50 | 2 | 15821257 | |
| Pubmed | 2.72e-04 | 17 | 50 | 2 | 39315665 | ||
| Pubmed | Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases. | 2.72e-04 | 17 | 50 | 2 | 27398409 | |
| Pubmed | Tgif1 and Tgif2 regulate Nodal signaling and are required for gastrulation. | 2.72e-04 | 17 | 50 | 2 | 20040491 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 2.92e-04 | 1201 | 50 | 8 | 35696571 | |
| Pubmed | 3.05e-04 | 18 | 50 | 2 | 12571105 | ||
| Pubmed | 3.05e-04 | 18 | 50 | 2 | 15689374 | ||
| Pubmed | 3.11e-04 | 225 | 50 | 4 | 12168954 | ||
| Pubmed | 3.41e-04 | 19 | 50 | 2 | 32290615 | ||
| Interaction | FLT3 interactions | GAGE5 GAGE6 GAGE7 GAGE13 GAGE12J GAGE12G GAGE1 HCK GAGE12F GAGE12I GAGE2E | 1.71e-10 | 318 | 48 | 11 | int:FLT3 |
| Interaction | ZFP41 interactions | 2.36e-07 | 57 | 48 | 5 | int:ZFP41 | |
| Interaction | GMCL1 interactions | 1.70e-06 | 154 | 48 | 6 | int:GMCL1 | |
| Interaction | CACNA1A interactions | 1.08e-05 | 123 | 48 | 5 | int:CACNA1A | |
| Interaction | PLAUR interactions | 1.70e-05 | 135 | 48 | 5 | int:PLAUR | |
| Interaction | IGFL3 interactions | 3.04e-05 | 75 | 48 | 4 | int:IGFL3 | |
| Interaction | GMCL2 interactions | 8.57e-05 | 36 | 48 | 3 | int:GMCL2 | |
| Interaction | GAGE2E interactions | 8.57e-05 | 36 | 48 | 3 | int:GAGE2E | |
| Interaction | GAGE12G interactions | 1.16e-04 | 7 | 48 | 2 | int:GAGE12G | |
| Interaction | CCN2 interactions | 1.18e-04 | 40 | 48 | 3 | int:CCN2 | |
| Interaction | HOXA1 interactions | 1.91e-04 | 356 | 48 | 6 | int:HOXA1 | |
| Interaction | GAGE8 interactions | 1.98e-04 | 9 | 48 | 2 | int:GAGE8 | |
| Interaction | NID1 interactions | 2.03e-04 | 48 | 48 | 3 | int:NID1 | |
| Interaction | MFAP5 interactions | 2.58e-04 | 52 | 48 | 3 | int:MFAP5 | |
| Cytoband | Xp11.23 | GAGE13 GAGE12J PPP1R3F GAGE12G GAGE12H GAGE1 GAGE12F GAGE12I GAGE2E | 1.10e-15 | 95 | 50 | 9 | Xp11.23 |
| Cytoband | Xp11.4-p11.2 | 1.86e-11 | 6 | 50 | 4 | Xp11.4-p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp11 | 7.63e-09 | 377 | 50 | 8 | chrXp11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 6.44e-03 | 681 | 50 | 4 | chr1p36 | |
| GeneFamily | Netrins | 3.71e-05 | 6 | 29 | 2 | 661 | |
| GeneFamily | Low density lipoprotein receptors | 1.92e-04 | 13 | 29 | 2 | 634 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.75e-03 | 57 | 29 | 2 | 1179 | |
| Coexpression | NABA_CORE_MATRISOME | 2.67e-07 | 270 | 43 | 7 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 3.03e-07 | 275 | 43 | 7 | M5884 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FAP_CELLS | 4.61e-07 | 179 | 43 | 6 | M41745 | |
| Coexpression | NABA_MATRISOME | PCSK5 HSPG2 FBLN1 NTNG2 MEGF6 NTNG1 CRELD2 NODAL TNXB MASP2 COL1A1 | 4.79e-07 | 1008 | 43 | 11 | MM17056 |
| Coexpression | NABA_MATRISOME | PCSK5 HSPG2 FBLN1 NTNG2 MEGF6 NTNG1 CRELD2 NODAL TNXB MASP2 COL1A1 | 5.70e-07 | 1026 | 43 | 11 | M5889 |
| Coexpression | SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER | 1.06e-06 | 47 | 43 | 4 | M11213 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.50e-05 | 191 | 43 | 5 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.70e-05 | 196 | 43 | 5 | M3008 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 3.89e-05 | 40 | 43 | 3 | M5887 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 1.44e-04 | 162 | 43 | 4 | M45037 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.72e-08 | 189 | 43 | 6 | feedac2751ed770f80bc56fec31662b5b3826f58 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-08 | 198 | 43 | 6 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Abcc9_(Mural.Rgs5Acta2.Abcc9)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.88e-08 | 102 | 43 | 5 | 8c4d9483ff983538593f4e17f4a74a93cdda59c4 | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Abcc9_(Mural.Rgs5Acta2.Abcc9)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.88e-08 | 102 | 43 | 5 | 72ce247dad7404e6b9c971b5c29d3c6846da5efc | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.88e-08 | 102 | 43 | 5 | 5feedce6d26a578c4aaba4e4824b3d0c3f3806bc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.87e-07 | 168 | 43 | 5 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.40e-07 | 171 | 43 | 5 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.38e-07 | 176 | 43 | 5 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.38e-07 | 176 | 43 | 5 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.03e-07 | 179 | 43 | 5 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.71e-07 | 182 | 43 | 5 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.95e-07 | 183 | 43 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 9.96e-07 | 187 | 43 | 5 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 189 | 43 | 5 | bc54ffd7bd1627a36747a80ce5139e4a69928400 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 189 | 43 | 5 | dde037322c8caec0c04c5be1c1b59a167824ad9f | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 190 | 43 | 5 | f3ca94a31a35eed5fecf3c4b8c957e1bc4150158 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 190 | 43 | 5 | c2cd1eb674162ee40502c3380b7245c85079c7ce | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 190 | 43 | 5 | 47077579496c5340e99f61499427a3a36b566da3 | |
| ToppCell | droplet-Mammary_Gland-nan-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 191 | 43 | 5 | 8022059e434fd411dc539819f969bd4f94861281 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-06 | 191 | 43 | 5 | 2b73fcd592d16cae8ded5e45c8fbf2d9adc8caad | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 191 | 43 | 5 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-06 | 191 | 43 | 5 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 191 | 43 | 5 | a57cf0519d749febc0b69fe0b098b7ba53d63258 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 191 | 43 | 5 | 19c67a812b8ce97472d316acd15aeefe8736000d | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 191 | 43 | 5 | 1efb47743b6834b64cb0f61721ddbe875b1a66ca | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-06 | 192 | 43 | 5 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-06 | 192 | 43 | 5 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-06 | 192 | 43 | 5 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-06 | 192 | 43 | 5 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-06 | 192 | 43 | 5 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-06 | 192 | 43 | 5 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-06 | 192 | 43 | 5 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-06 | 192 | 43 | 5 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-06 | 192 | 43 | 5 | 011634a24b0c61d9b463fe755502edbc5cd70b7a | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 193 | 43 | 5 | ebd090d7801480b3cee45caac3d30cc991836769 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 193 | 43 | 5 | 22c58032e58730715224d7934968ce92d150b0e8 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 193 | 43 | 5 | f95b95c58a6edb8a03dd15ae166f47f9f33d8bd6 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 193 | 43 | 5 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 193 | 43 | 5 | 428b1a3ad87dff7f65de5161d40f102572a9341b | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-06 | 193 | 43 | 5 | e27885a9e1a2a3e165c5366d4cfcda05c5454483 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.16e-06 | 193 | 43 | 5 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 193 | 43 | 5 | eff718664fe0aaf89050efd9cc7b6dfb1df46666 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 193 | 43 | 5 | 85faf6c5ce4769615a4eca036e2ba307e176bb52 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 193 | 43 | 5 | 573ad2f848bede1fe20c7b4b352a9242ec294725 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 193 | 43 | 5 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 193 | 43 | 5 | 110a7d2ba7d066c2be38be98b643b76c520dd980 | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|World / Lineage and Cell class | 1.19e-06 | 194 | 43 | 5 | c1e8923a50b4138a1e4c054c0c17b7f7122aa8a9 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-06 | 195 | 43 | 5 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-06 | 195 | 43 | 5 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-06 | 195 | 43 | 5 | 0feb6ebe7b4b781dec7cfaef844140cfbf84b4b9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-06 | 195 | 43 | 5 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-06 | 195 | 43 | 5 | 2a6f67875cef140b0e6b8401436719675c6b3665 | |
| ToppCell | Mesenchymal_cells|World / Lineage and Cell class | 1.22e-06 | 195 | 43 | 5 | 380eb436baa371f7aa2dc0c4a594afb173b5a25b | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-06 | 195 | 43 | 5 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-06 | 195 | 43 | 5 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | PND28-Mesenchymal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-06 | 196 | 43 | 5 | 119265efd2219f328d8152dbee52af8327aec89c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.29e-06 | 197 | 43 | 5 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-06 | 197 | 43 | 5 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|Mesenchymal_cells / Lineage and Cell class | 1.29e-06 | 197 | 43 | 5 | cb321836980e7b4efbb9284c6af7ccd34079d2be | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-E_(AT2)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.32e-06 | 198 | 43 | 5 | 498f11441c0a0982738537bcfcfc2877866b7400 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-06 | 198 | 43 | 5 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.35e-06 | 199 | 43 | 5 | 8766796041965a1ba40ad7abdbc244bf1418c209 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.35e-06 | 199 | 43 | 5 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.35e-06 | 199 | 43 | 5 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.35e-06 | 199 | 43 | 5 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.35e-06 | 199 | 43 | 5 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.35e-06 | 199 | 43 | 5 | 1fd7bbb8727607e6507848602a19bc86882ef2d5 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.35e-06 | 199 | 43 | 5 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.35e-06 | 199 | 43 | 5 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.35e-06 | 199 | 43 | 5 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.35e-06 | 199 | 43 | 5 | f19c683f38bca3bfee40396f27423441051dec67 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.35e-06 | 199 | 43 | 5 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.35e-06 | 199 | 43 | 5 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.35e-06 | 199 | 43 | 5 | d39b40d84c72bdde756b805063317ecfad3784f8 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.39e-06 | 200 | 43 | 5 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.39e-06 | 200 | 43 | 5 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.39e-06 | 200 | 43 | 5 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.39e-06 | 200 | 43 | 5 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-06 | 200 | 43 | 5 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.39e-06 | 200 | 43 | 5 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.39e-06 | 200 | 43 | 5 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-06 | 200 | 43 | 5 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.39e-06 | 200 | 43 | 5 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.39e-06 | 200 | 43 | 5 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-06 | 200 | 43 | 5 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-06 | 200 | 43 | 5 | 74ad0ae592252060ee294d7483327d765a6ba1dd | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-06 | 200 | 43 | 5 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 1.39e-06 | 200 | 43 | 5 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.39e-06 | 200 | 43 | 5 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-06 | 200 | 43 | 5 | 7ba292c30d915e66ebc8026fa76492cedf64700e | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.39e-06 | 200 | 43 | 5 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-06 | 200 | 43 | 5 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-06 | 200 | 43 | 5 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Ccnd1_(Mural.Rgs5Acta2.Ccnd1)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.25e-06 | 96 | 43 | 4 | d98df92856840602a82d3f050bf0a1543445cac0 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Ccnd1_(Mural.Rgs5Acta2.Ccnd1)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.25e-06 | 96 | 43 | 4 | bf62c29da66aa3eefdc59337dfb3cd0467f04f10 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.17e-06 | 112 | 43 | 4 | 88fcd0dc12b5c00804381fb7dd59a6a2a9f37419 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.17e-06 | 112 | 43 | 4 | fd4cc5190626cb262aae0a7f04559b0e9757270e | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.17e-06 | 112 | 43 | 4 | d652e6fae433a6b56bf2a448fba2cf6c5e558905 | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.32e-06 | 113 | 43 | 4 | 0651fb7a7e1ea84b8365059e5ed85bf6c082da1a | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8-MURAL_Mural.Acta2Rgs5.Kcnj8-Abcc9_(Mural.Acta2Rgs5.Kcnj8-Abcc9)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.32e-06 | 113 | 43 | 4 | 0e153efddd061d7510dfc3859cc8b1a7984fa70e | |
| Computational | Trachea genes. | 1.25e-05 | 415 | 22 | 7 | MODULE_6 | |
| Computational | Ovary genes. | 7.24e-05 | 368 | 22 | 6 | MODULE_1 | |
| Computational | Placenta genes. | 2.56e-04 | 463 | 22 | 6 | MODULE_38 | |
| Computational | Spinal cord (neuro-development) genes. | 6.74e-04 | 360 | 22 | 5 | MODULE_12 | |
| Computational | Liver genes - metabolism and xenobiotics. | 7.30e-04 | 563 | 22 | 6 | MODULE_23 | |
| Computational | DRG (dorsal root ganglia) genes. | 9.03e-04 | 384 | 22 | 5 | MODULE_2 | |
| Computational | ECM and collagens. | 1.02e-03 | 225 | 22 | 4 | MODULE_47 | |
| Computational | Heart genes. | 1.39e-03 | 423 | 22 | 5 | MODULE_60 | |
| Computational | Lung genes. | 1.56e-03 | 434 | 22 | 5 | MODULE_5 | |
| Drug | indene | 4.81e-06 | 120 | 47 | 5 | CID000007219 | |
| Drug | LMWH | 7.22e-06 | 663 | 47 | 9 | CID000000772 | |
| Drug | hexadecanol | 1.48e-05 | 72 | 47 | 4 | CID000002682 | |
| Drug | 1ct8 | 2.83e-05 | 173 | 47 | 5 | CID000444888 | |
| Drug | AC1Q6AQ7 | 4.21e-05 | 188 | 47 | 5 | CID000005515 | |
| Drug | Piperine [94-62-2]; Down 200; 14uM; PC3; HT_HG-U133A | 4.54e-05 | 191 | 47 | 5 | 4247_DN | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; PC3; HT_HG-U133A | 4.66e-05 | 192 | 47 | 5 | 4268_UP | |
| Drug | Cephaloridine | 4.70e-05 | 470 | 47 | 7 | ctd:D002509 | |
| Drug | Heliotrine [303-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 5.14e-05 | 196 | 47 | 5 | 4739_UP | |
| Disease | Migraine Disorders | 4.73e-07 | 13 | 36 | 3 | C0149931 | |
| Disease | netrin-G1 measurement | 4.34e-06 | 3 | 36 | 2 | EFO_0801825 | |
| Disease | Abdominal Migraine | 5.18e-05 | 9 | 36 | 2 | C0270858 | |
| Disease | Sick Headaches | 5.18e-05 | 9 | 36 | 2 | C0700438 | |
| Disease | Acute Confusional Migraine | 5.18e-05 | 9 | 36 | 2 | C0521664 | |
| Disease | Status Migrainosus | 5.18e-05 | 9 | 36 | 2 | C0338489 | |
| Disease | Cervical Migraine Syndrome | 5.18e-05 | 9 | 36 | 2 | C0007852 | |
| Disease | Hemicrania migraine | 5.18e-05 | 9 | 36 | 2 | C0018984 | |
| Disease | response to bisphosphonate, osteonecrosis | 6.47e-05 | 10 | 36 | 2 | EFO_0004259, EFO_0009958 | |
| Disease | Schizophrenia | 8.21e-05 | 883 | 36 | 7 | C0036341 | |
| Disease | FEV/FEC ratio | 9.40e-05 | 1228 | 36 | 8 | EFO_0004713 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 1.72e-04 | 16 | 36 | 2 | C4551479 | |
| Disease | Spondyloepiphyseal Dysplasia | 1.72e-04 | 16 | 36 | 2 | C0038015 | |
| Disease | Schwartz-Jampel Syndrome | 1.72e-04 | 16 | 36 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 1.72e-04 | 16 | 36 | 2 | C0025237 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 1.72e-04 | 16 | 36 | 2 | C3541456 | |
| Disease | Van Buchem disease | 1.95e-04 | 17 | 36 | 2 | C0432272 | |
| Disease | Dyschondroplasias | 2.44e-04 | 19 | 36 | 2 | C0013366 | |
| Disease | Osteochondrodysplasias | 2.44e-04 | 19 | 36 | 2 | C0029422 | |
| Disease | Multiple Epiphyseal Dysplasia | 2.71e-04 | 20 | 36 | 2 | C0026760 | |
| Disease | Antimigraine preparation use measurement | 3.00e-04 | 21 | 36 | 2 | EFO_0009939 | |
| Disease | Postural instability | 4.27e-04 | 25 | 36 | 2 | HP_0002172 | |
| Disease | diabetes mellitus (implicated_via_orthology) | 4.62e-04 | 26 | 36 | 2 | DOID:9351 (implicated_via_orthology) | |
| Disease | white matter hyperintensity measurement | 4.89e-04 | 302 | 36 | 4 | EFO_0005665 | |
| Disease | colorectal cancer (implicated_via_orthology) | 6.16e-04 | 30 | 36 | 2 | DOID:9256 (implicated_via_orthology) | |
| Disease | intestinal cancer (implicated_via_orthology) | 7.01e-04 | 32 | 36 | 2 | DOID:10155 (implicated_via_orthology) | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 9.82e-04 | 364 | 36 | 4 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian serous carcinoma | 1.21e-03 | 42 | 36 | 2 | EFO_0004920, EFO_1001516, GO_0097328, MONDO_0009354 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GAAPECSCGDPLLDP | 441 | Q8NFU1 | |
| CTPEAEGRPEEPCGE | 151 | Q9H211 | |
| GPGLRPCAPLEDECE | 201 | Q9NYJ7 | |
| EDGSDELDCGPPPPC | 311 | P98160 | |
| TEEPEECGPASCPES | 126 | O75154 | |
| CECEDGPDGQEMDPP | 86 | P0DTW1 | |
| SDEPDDCPEFRCQPG | 3346 | Q9NZR2 | |
| HETCPDDPCEDPGPT | 1211 | Q9HCH0 | |
| CECEDGPDGQEMDPP | 86 | O76087 | |
| RDCPDGSDEAPEICP | 51 | Q07954 | |
| CECEDGPDGQEMDPP | 86 | Q4V326 | |
| CDPECSEVGCDGPGP | 636 | Q92824 | |
| SCGCPEGAELRAPPD | 21 | Q9UHG3 | |
| GVGDLDEDPKCPCPS | 11 | Q9UGI6 | |
| LCEINEDDCGPGPPL | 1156 | Q9UM47 | |
| GEDCRSEDPPDELGP | 41 | Q8TAA5 | |
| DVDECAPPAEPCGKG | 356 | P23142 | |
| SCEDPGCPRDEERAP | 6 | P08631 | |
| CECEDGPDGQEMDPP | 86 | A1L429 | |
| CECEDGPDGQEMDPP | 86 | P0CL80 | |
| CECEDGPDGQEMDPP | 86 | P0CL81 | |
| CECEDGPDGQEMDPP | 86 | A6NDE8 | |
| CECEDGPDGQEMDPP | 86 | P0CL82 | |
| CECEDGPDGQEMDPP | 86 | A6NER3 | |
| PAPSCEREPSGDENC | 2671 | Q8TD26 | |
| CECEDGPDGQEVDPP | 86 | Q13070 | |
| VPGCQAELCDDDPPE | 16 | P01589 | |
| CSIVDCGPPDDLPSG | 361 | O00187 | |
| CECEDGPDGQEMDPP | 86 | Q4V321 | |
| CECEDGPDGQEMDPP | 86 | Q13069 | |
| GACVDVDECAAEPPP | 226 | Q6UXH1 | |
| ECGRGEPQCSPAGPE | 101 | Q9UL51 | |
| PPGRTGEDCEADCPE | 761 | O75095 | |
| DPPDITCGDPPETFC | 66 | Q9Y2I2 | |
| CEQPRCDPADDDGGL | 486 | Q96CW9 | |
| PAGEEPVRCDACPEG | 121 | Q96LD4 | |
| CEGECPNPVGEEFHP | 276 | Q96S42 | |
| CECEDGPDGQEMDPP | 86 | P0DSO3 | |
| PPGLDEEPTFRCDEC | 221 | Q9HAZ2 | |
| EPPADLAPLACGECG | 296 | O95785 | |
| DAGSPRGCPLCPDDC | 156 | Q9BRJ9 | |
| PRCEDPCPTGTFGED | 336 | Q14162 | |
| CLCPLPEDPGDEEGG | 566 | Q6PIS1 | |
| DPEMCPENGSCVPDG | 161 | Q6UW56 | |
| VPEGECCPVCPDGSE | 86 | P02452 | |
| CDVPAGEGQCPSLEP | 1296 | O15417 | |
| EFGGECPADPLPCEE | 121 | Q8IUB2 | |
| EDCGQEEPPASACPG | 676 | P22105 | |
| GEEEEEACPEPSPLC | 91 | Q6ZSY5 | |
| ACPECREPFPDGAEL | 46 | Q6PJ69 | |
| APEESEPGCEAPCAG | 6 | Q6PF15 |